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Objectives:Aortic Customize is a new concept for endo-
vascular aortic aneurysm repair in which a nonpolymerised
elastomer is injected to fill the aneurysm sac around a balloon-
catheter. Aim of this in-vitro study was to investigate the
extent of aneurysm wall stress reduction by the presence of an
elastomer cuff.
Methods: A latex aneurysm (inner radius sac 18mm,
inner radius neck 8mm), equipped with 12 tantalummarkers,
was attached to an in-vitro circulation model. Fluoroscopic
roentgenographic stereo photogrammetric analysis (FRSA)
was used to measure marker movement during 6 cardiac
cycles. The radius of 3 circles drawn through the markers was
measured before and after sac-filling. Wall movement was
measured at different systemic pressures. Wall-stress was cal-
culated from the measured radius (
  pr/2t).
Results: The calculated wall-stress was 7.5-15.6 N/cm2
before sac-filling and was diminished to 0.43-1.1 N/cm2
after sac-filling. Before sac-filling there was a clear increase
(p  0, 001) in radius of the proximal (range 7.9% - 33.5%),
middle (range 3.3% - 25.2%) and distal (range 10.5% -
184.3%) rings with increasing systemic pressure. After sac-
filling with the elastomer there remained a small, significant
(p 0, 001), increase in the radius of the circles (ranges 6.8% -
8.8%; 0.7% - 1.1%; 5.3% - 6.7%). The sac-filling reduced the
extent of radius increase. The treated aneurysm withstood
pressures up to 220/140 mm Hg without noticeable wall-
movement.
Conclusions: Filling the aneurysm sac with a biocom-
patible elastomer leads to successful exclusion of the aneu-
rysm sac from the circulation. Wall-movement and calcu-
lated wall stress are diminished noticeably by the injection
of biocompatible elastomer.
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Objectives: Endovascular repair (EVAR) of infrarenal
aortic aneurysms (AAA) is increasingly utilized in patients
with suitable aortic morphology. Despite improvements in
graft design, type II endoleak (EL-2) either from theinferior mesenteric artery (EL-IMA) or lumbar artery (EL-
LA) remains the Achilles’ heel of EVAR. The objective of
this study is to evaluate AAA sac diameter in patients with
and without EL-2. Our hypothesis is: persistent EL-2 is
associated with inferior sac regression.
Methods: Retrospective analysis of all nonruptured AAA
treated by elective EVAR using FDA-approved endografts
from January 2005 to December 2008 at Mercy Medical
Center, Des Moines, IA was performed. Review of medical
records, preoperative and follow-upCT angiograms (CTA) at
1 and 6 months were performed. Patients with type I, III and
IV endoleak were excluded. Change in AAA sac diameter at 6
months was compared in patients: 1) with and without EL-2;
2) with occluded vs patent IMA.
Results: The study cohort comprised of 198 patients (165
men, 33 women, mean age 74 years). Mean preoperative AAA
diameter was 5.5 cm (range 4-11 cm). EL-2 was present in 27%
at completion of EVAR and persisted in 9% at amean follow-up
of 6 months (range 4-8 months). 94% of EL-LA resolved on
follow-up vs 55%ofEL-IMA(p0.01, Fisher exact test).Mean
change in sac diameter at 6 months was 0.04 cm in patients
with EL-2 vs0.48 cm in patients without EL-2 (p 0.002, t
test). Preoperatively, the IMA was occluded by coils or chroni-
cally occluded in 92 patients vs 105 patients who had a patent
IMA. At 6months, mean change in sac diameter was0.06 cm
in patients with a patent IMA vs 0.57 cm in patients with an
occluded IMA (p 0.001, t test).
Conclusions: Persistent EL-2 following EVARoccurred
in 9% of patients, predominantly from the IMA. 55% of
EL-IMA did not resolve and lead to increase in sac diameter.
Occlusion of the IMA led to greater sac shrinkage following
EVAR and should be considered when the IMA is widely
patent.
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Objectives: To examine the mortality and morbidity of
Crawford type IV thoracoabdominal aortic aneurysm (TAAA)
repair at a single university hospital over 10 years.
Methods: All patients undergoing open type IV TAAA
repair between 1998 and 2008 were prospectively entered
into a database (n 108). Repairs were performed through
a left retroperitoneal incision.
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mean age of 72.9 years, underwent open type IV TAAA
repair. Nine patients (8.3%) were ruptured. Mean aneurysm
maximal diameter was 6.5  1.3 cm. Supraceliac and left
kidney ischemia were 22.9  9.3 and 40.6  16.2 minutes,
respectively. Mean blood loss was 2.5 liters. 6 patients (5.9%)
died at 30 days; of these one was ruptured preoperatively. No
preoperative or intraoperative factor predicted early mortality.
Major complication rate was 25.9% (n  28). Patients with
symptomatic aneurysms were predisposed tomajor complica-
tion (p  .029). Six patients (5.9%) required initiation of
long-term dialysis; this was associated with preoperative creat-
inine clearance  37 mL/min (p  .041). In order to assess
the effect of left renal artery bypass (LRAB) on patient out-
come, comparison was made to 50 patients who underwent
pararenal AAA (PRAAA) repair with supraceliac clamping but
without LRAB (Table 1).
Conclusions:Ourexperiencedemonstrates thatopen type
IV TAAA repair can be performed with relatively lowmorbidity
and mortality. In addition, type IV TAAA and PRAAA repairs
had comparable morbidity and mortality, suggesting that the
morbidity of type IVTAAA repair is due to supraceliac ischemia.





(n  50) P-value
Ruptured aneurysm 9 (8.3%) 6 (12%) 0.66
Duration of supraceliac
ischemia (min)
22.9  9.3 21.3  7.9 0.33
Duration of left renal
artery ischemia (min)
40.3  16.2 21.2  7.8 0.001
Mortality 6 (5.6%) 4 (8%) 0.814
Major complication 28 (25.9%) 12 (24%) 0.950
Long-term hemodialysis 6 (5.9%) 0 (0%) 0.198
Author Disclosures: C. Brinster: Nothing to disclose;
J. Carpenter: Nothing to disclose; R. M. Fairman: Nothing
to disclose; B. M. Jackson: Nothing to disclose; D. Nathan:
Nothing to disclose; E. Y. Woo: Nothing to disclose.
PS56.
Endovascular Salvage of Collapsed Thoracic En-
dografts - A Multicenter Review
Rami O. Tadros1, Peter Faries1, Tejas R. Shah1, Daniel K.
Han1, Amit R. Shah2, Evan C. Lipsitz2, Rabih Chaer3,
Michael Marin1, Jae Cho3. 1Mount Sinai Medical Center,
New York, NY; 2Montefiore Medical Cente, Bronx, NY;
3University of Pittsburgh Medical Center, Pittsburgh, PA
Objectives: Thoracic endograft collapse after thoracic
endovascular aortic repair (TEVAR) is a potentially devas-
tating complication. This study aims to evaluate the man-
agement of thoracic stent graft collapse.
Methods: A multicenter review was performed from
2005-2009. Diagnosis and preoperative planning was per-
formed by CT angiography. Outcome measures included
the success of endovascular salvage, postoperative compli-
cations and conversion to open repair.Results: 12 cases of endograft collapseweremanaged in11
patients, 10 males and 1 female. Mean age was 41.2 (range,
21-66 years). 8 had aortic transections. 3 had type B dissections.
All were initially treated with TAG endografts (W. L Gore,
Flagstaff, AZ). All collapses were treated by redo TEVAR. The
median duration from initial repair to collapsewas 9 days (range,
1-1126days).Highradial forcedeviceswereused in5casesusing
Talent thoracic stent grafts (Medtronic, Santa Rosa, CA) in 3
cases and Palmaz stents (Cordis, Miami, FL) in 2 cases with
re-expansion of all 5 grafts. TAG endografts were used in 7 cases
with re-expansion of 6 grafts. The persistent collapse was man-
aged with a Palmaz stent. This was complicated by an iatrogenic
type A dissection. The overall complication rate with re-grafting
using TAG endografts was 43%. Late complications following
redo TEVAR included an aortoesophageal fistula and persistent
physiologic coarctation, which were both treated by open con-
version. 2 additional patients underwent open conversion; 1 for
an aforementioned type A dissection, and another elective con-
version toprevent a recurrent collapse fromseverebird’sbeaking.
The overall open conversion rate was 36%.
Conclusions: Stent graft collapse can be effectively
and safely managed by endovascular techniques. Redo
TEVAR using high radial force devices should be con-
sidered the initial treatment of choice. Based on this case
series, failed endovascular salvage of collapsed en-
dografts can successfully be managed with open repair
without added mortality.
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Objectives: To assess the functional status of kidneys
and determine if reanastomosis of the left renal vein
(RLRV) provides any advantage over ligation of left renal
vein (LLRV).
Methods: Three hundred eighty four patients under-
went abdominal aortic aneurysm repair (AAA) from 1999 to
2009. Twenty-six patients (6.8%) had juxtarenal AAAs and 24
required division of the left renal vein. In ten out of those 24,
RLRV was performed. Patency of the anastomosed left renal
vein was confirmed by intraoperative duplex scan. The re-
maining 14 patients underwent LLRV medial to adrenal and
gonadal veins. Preoperative creatinine clearance (Cockroft-
Gault equation) was compared in both groups at postopera-
tive day seven and at long-term follow-up. All patients in the
LLRV group underwent either nuclear scan (n9) or CT an-
giography (n5) for assessment of functional status of each
kidney at long-term follow-up.
